GPX4 and ovarian carcinoma: Carboxymethylated pachyman (CMP) inhibited HO-1 signaling, xCT, and GPX4, as well as upregulated Fe2+ expression by downregulating NRF2 expression, ultimately leading to the induction of ferroptosis in ovarian cancer cells.